Economic and socio-economic benefits of R&D-based multinational pharmaceuticals on the SA economy
(ACC33GCL)

This article sets out to demonstrate how Corporate Social Investment activities significantly exceed their costs, as well as the intangible benefits that CSI brings to the South African economy/ community.